Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REATA-PHARMACEUTICALS-INC-28377265/news/Biologics-by-McKesson-Named-the-Exclusive-Pharmacy-for-FDA-Approved-SKYCLARYS-for-the-Treatment-of-F-43444678/?utm_source=whatsapp&utm_medium=social&utm_campaign=share